pI: 4.8324 |
Length (AA): 326 |
MW (Da): 32947 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 5 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
6 | 325 | 1zq1 (A) | 85 | 419 | 25.00 | 0 | 1 | 1.2021 | 0.14 |
12 | 326 | 5mq5 (A) | 1 | 324 | 29.00 | 0 | 1 | 1.28976 | -0.59 |
14 | 321 | 5ot0 (A) | 2 | 313 | 32.00 | 0 | 1 | 1.34449 | -0.51 |
14 | 321 | 5k4g (A) | 5 | 323 | 30.00 | 0 | 1 | 1.28249 | -0.44 |
201 | 270 | 5vmt (A) | 86 | 150 | 42.00 | 0.52 | 0.87 | 0.498424 | 0.72 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Dormant phase, Dormant phase. | hasan murphy |
hasan | Prioritizing genomic drug targets in pathogens: application to Mycobacterium tuberculosis. |
murphy | Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. |
Ortholog group members (OG5_127035)
Species | Accession | Gene Product |
---|---|---|
Brugia malayi | Bm1_50405 | L-asparaginase |
Candida albicans | CaO19.7593 | likely asparaginase similar to S. cerevisiae ASP1 (YDR321W) |
Caenorhabditis elegans | CELE_C27A7.5 | Protein C27A7.5, isoform D |
Dictyostelium discoideum | DDB_G0271924 | L-asparaginase I |
Drosophila melanogaster | Dmel_CG8526 | CG8526 gene product from transcript CG8526-RA |
Drosophila melanogaster | Dmel_CG6428 | CG6428 gene product from transcript CG6428-RA |
Escherichia coli | b2957 | periplasmic L-asparaginase 2 |
Escherichia coli | b1767 | cytoplasmic L-asparaginase 1 |
Echinococcus granulosus | EgrG_000796600 | Asparaginase glutaminase |
Echinococcus granulosus | EgrG_001165500 | Ankyrin |
Entamoeba histolytica | EHI_178920 | L-asparaginase, putative |
Entamoeba histolytica | EHI_050740 | L-asparaginase, putative |
Echinococcus multilocularis | EmuJ_000796600 | Asparaginase glutaminase |
Echinococcus multilocularis | EmuJ_001165500 | Ankyrin |
Giardia lamblia | GL50803_14547 | L-asparaginase |
Homo sapiens | ENSG00000166183 | asparaginase |
Leishmania braziliensis | LbrM.35.4670 | asparaginase-like protein |
Leishmania braziliensis | LbrM.15.0410 | cytoplasmic l-asparaginase i-like protein |
Leishmania donovani | LdBPK_150440.1 | cytoplasmic l-asparaginase i-like protein |
Leishmania donovani | LdBPK_364650.1 | asparaginase-like protein |
Leishmania infantum | LinJ.36.4650 | asparaginase-like protein |
Leishmania infantum | LinJ.15.0440 | cytoplasmic l-asparaginase i-like protein |
Leishmania major | LmjF.36.4430 | asparaginase-like protein |
Leishmania major | LmjF.15.0390 | cytoplasmic l-asparaginase i-like protein |
Leishmania mexicana | LmxM.15.0390 | cytoplasmic l-asparaginase i-like protein |
Leishmania mexicana | LmxM.36.4430 | asparaginase-like protein |
Loa Loa (eye worm) | LOAG_00838 | hypothetical protein |
Mycobacterium leprae | ML1198c | Probable L-aparaginase AnsA |
Mus musculus | ENSMUSG00000037686 | asparaginase homolog (S. cerevisiae) |
Mycobacterium tuberculosis | Rv1538c | Probable L-aparaginase AnsA |
Mycobacterium ulcerans | MUL_1536 | L-aparaginase AnsA |
Neospora caninum | NCLIV_041200 | asparaginase, putative |
Saccharomyces cerevisiae | YLR155C | asparaginase ASP3-1 |
Saccharomyces cerevisiae | YDR321W | asparaginase ASP1 |
Saccharomyces cerevisiae | YLR160C | asparaginase ASP3-4 |
Saccharomyces cerevisiae | YLR157C | asparaginase ASP3-2 |
Saccharomyces cerevisiae | YLR158C | asparaginase ASP3-3 |
Schistosoma japonicum | Sjp_0109050 | IPR002110,Ankyrin,domain-containing |
Schistosoma japonicum | Sjp_0106020 | ko:K01048 lysophospholipase [EC3.1.1.5], putative |
Schistosoma japonicum | Sjp_0003290 | ko:K01048 lysophospholipase [EC3.1.1.5], putative |
Schistosoma mansoni | Smp_153810 | l-asparaginase I |
Schmidtea mediterranea | mk4.027277.00 | Putative l-asparaginase I |
Schmidtea mediterranea | mk4.034237.03 | |
Schmidtea mediterranea | mk4.059437.00 | |
Schmidtea mediterranea | mk4.002597.00 | Putative l-asparaginase I |
Trypanosoma cruzi | TcCLB.504147.110 | asparaginase, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
mtu1566 this record | Mycobacterium tuberculosis | non-essential | nmpdr |
b1767 | Escherichia coli | non-essential | goodall |
b2957 | Escherichia coli | non-essential | goodall |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
33 literature references were collected for this gene.